Adjuvin and Sertralin Filmtabletten
Recall
|
Medicines
|
06/04/2022
The marketing authorisation holder informed its customers on April 05, 2022, that a microbiologically contaminated excipient was used in the batches mentioned.
For that reason, the affected batches are recalled as a precautionary measure.
| Name of the medicinal product | 1) Adjuvin 50 mg-Filmtabletten 2) Adjuvin 100 mg-Filmtabletten 3) Sertralin G.L. 100 mg-Filmtabletten |
|---|---|
| Marketing authorisation number(s) | 1) 1-25974 2) 1-25975 3) 1-25973 |
| CIP code | 1) 2474475 2) 2474481 3) 3507923 |
| Marketing authorisation holder | G.L. Pharma GmbH |
| Batch number(s) | 1) E06691 2) E03442 3) E02765 |
| Expiry date | 07/31/2026 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3821 |
Further inquiry note
Page last modified:
06/04/2022